Evidence map›Paper›PMID 33585555›Full record

ArticleFrontiers in molecular biosciences2020

Human Cerebral Cortex Proteome of Fragile X-Associated Tremor/Ataxia Syndrome.

Katharine Nichole Holm, Anthony W Herren, Sandra L Taylor, Jamie L Randol, Kyoungmi Kim, Glenda Espinal, Verónica Martiínez-Cerdeño, Isaac N Pessah, Randi J Hagerman, Paul J Hagerman

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Katharine Nichole HolmDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine, Davis, CA, United States.
Anthony W HerrenMass Spectrometry Research Core, University of California Davis, Davis, CA, United States.
Sandra L TaylorDepartment of Public Health Sciences, Division of Biostatistics, University of California Davis School of Medicine, Davis, CA, United States.
Jamie L RandolDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine, Davis, CA, United States.
Kyoungmi KimDepartment of Public Health Sciences, Division of Biostatistics, University of California Davis School of Medicine, Davis, CA, United States.
Glenda EspinalDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine, Davis, CA, United States.
Verónica Martiínez-CerdeñoMedical Investigation of Neurodevelopmental Disorders Institute, University of California Davis School of Medicine, Davis, CA, United States.
Isaac N PessahMedical Investigation of Neurodevelopmental Disorders Institute, University of California Davis School of Medicine, Davis, CA, United States.
Randi J HagermanMedical Investigation of Neurodevelopmental Disorders Institute, University of California Davis School of Medicine, Davis, CA, United States.
Paul J HagermanDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine, Davis, CA, United States.
University of California, Davis · US

Funding

UC Davis Clinical and Translational Science CenterUL1TR001860 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KENYON, NICHOLAS J., LYLES, COURTNEY REES · 2016 to 2025
$47.3M
GENOTYPE/PHENOTYPE RELATIONSHIPS IN FRAGILE X FAMILIESR01HD036071 · NICHD · UNIVERSITY OF CALIFORNIA DAVIS · PI PAUL J HAGERMAN, RANDI J. HAGERMAN · 1998 to 2026
$13.8M
Research Project: Pathologic Significance of Maternal AutoantibodiesP50HD103526 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEONARD J. ABBEDUTO, Melissa Dawn Bauman · 2020 to 2026
$9.7M
Molecular and Cellular Basis of PCB Developmental Neurotoxicity: ViCTER supplementR01ES014901 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HANS-JOACHIM LEHMLER, Pamela J Lein · 2009 to 2026
$9.3M
Fragile X-associated tremor/ataxia syndrome (FXTAS) pathology and anatomy: imaging and clinical correlatesR01NS107131 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MARTINEZ-CERDENO, VERONICA · 2018 to 2022
$2.6M
Molecular and Cellular Basis of PCB Developmental NeurotoxicityR56ES014901 · NIEHS · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEIN, PAMELA J · 2007 to 2007
$150k
NCATS NIH HHS UL1 TR001860NICHD NIH HHS P50 HD103526NICHD NIH HHS R01 HD036071NIEHS NIH HHS R01 ES014901NIEHS NIH HHS R56 ES014901NINDS NIH HHS R01 NS107131
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CD38DIA-MSFMR1FMRpolyGFragile X SyndromeFXTASSUMO1/2Tenascin-C

Identifiers

PMID33585555
PMCPMC7879451
OpenAlexW3127123636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.